Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The IR, IGF-1R and their hybrid receptors are expressed by most human tumors, whereby predominant expression of the IR-A isoform correlates with a poor differentiation grade
This occurred in one of the volunteers on 4.5 mg weekly
Dose calculations at 5,000 mcg/mL: 1mg dose = 0.2mL = 20 units on U-100 syringe 2mg dose = 0.4mL = 40 units 4mg dose = 0.8mL = 80 units 6mg dose = 1.2mL = 120 units 8mg dose = 1.6mL = 160 units 12mg dose = 2.4mL = 240 units This dilution makes higher doses more practical within a single syringe for mid-range protocols
However, it's worth noting that because A1C reflects roughly three months of average blood sugar, a 12-week study is arguably too short to capture the full effectiveness a limitation the study authors also mentioned
Common GI side effects (affecting more than 1 in 10 people) according to the SmPC: Nausea : The most frequent side effect, reported in approximately 44% of patients in clinical trials, usually most pronounced during the first few weeks and with dose increases Diarrhoea : Affects roughly 30% of users, typically mild to moderate and transient Vomiting : Occurs in about 24% of patients, often associated with eating too quickly or consuming large portions Constipation : Reported in approximately 24% of users, which may require dietary modification or occasional laxative use Abdominal pain or discomfort : Affects around 20% of patients, usually described as cramping or bloating Dyspepsia and reflux : Indigestion and heartburn occur in approximately 9% of users Less common but significant GI effects : Delayed gastric emptying : Whilst this is the intended pharmacological effect, in some cases it can cause persistent nausea, vomiting, and inability to tolerate food Pancreatitis : Has been reported in clinical trials and post-marketing
SUGESTO DE USO E BENEFCIOS DESENVOLVIDOS POR PROFISSIONAL HABILITADO
